Keenova Therapeutics plc Accumulated Other Comprehensive Income
Keenova Therapeutics plc had Accumulated Other Comprehensive Income of -$3.60 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-11
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.60M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.50M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.00M.
- 2025-09-26: Accumulated Other Comprehensive Income (Loss), Net of Tax $13.30M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$3.60M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | -$1.50M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $1.00M 10-Q · filed 2026-08-11 | |
| 2025-09-26 | $13.30M 10-Q · filed 2025-11-10 | |
| 2025-06-27 | $13.90M 10-Q · filed 2025-08-06 | |
| 2025-03-28 | $9.20M 10-Q · filed 2025-05-12 | |
| 2024-12-27 | $6.10M 10-K · filed 2026-04-15 | |
| 2024-09-27 | $2.80M 10-Q · filed 2024-11-05 | |
| 2024-06-28 | -$4.70M 10-Q · filed 2024-08-06 | |
| 2024-03-29 | -$1.20M 10-Q · filed 2024-05-09 | |
| 2023-12-29 | $3.60M 10-K · filed 2025-03-13 | |
| 2023-09-29 | $13.50M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $14.60M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $8.20M 10-Q · filed 2023-05-09 | |
| 2022-12-30 | $10.80M 10-K · filed 2024-03-26 | |
| 2022-09-30 | -$6.40M 10-Q · filed 2022-11-08 | |
| 2022-07-01 | -$1.70M 10-Q · filed 2022-08-11 | |
| 2022-04-01 | -$8.30M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | -$8.30M 10-K · filed 2023-03-03 | |
| 2021-09-24 | -$10.50M 10-Q · filed 2021-11-02 | |
| 2021-06-25 | -$9.20M 10-Q · filed 2021-08-03 | |
| 2021-03-26 | -$9.50M 10-Q · filed 2021-05-04 | |
| 2020-12-25 | -$9.60M 10-K · filed 2022-03-15 | |
| 2020-09-25 | -$8.40M 10-Q · filed 2020-11-03 | |
| 2020-06-26 | -$8.80M 10-Q · filed 2020-08-04 | |
| 2020-03-27 | -$9.20M 10-Q · filed 2020-05-06 | |
| 2019-12-27 | -$7.90M 10-K · filed 2021-03-10 | |
| 2019-09-27 | -$22.10M 10-Q · filed 2019-11-05 | |
| 2019-06-28 | -$20.10M 10-Q · filed 2019-08-06 | |
| 2019-03-29 | -$22.50M 10-Q · filed 2019-05-07 | |
| 2018-12-28 | -$24.30M 10-K · filed 2020-02-26 | |
| 2018-09-28 | -$18.70M 10-Q · filed 2019-11-05 | |
| 2018-06-29 | -$21.70M 10-Q · filed 2019-08-06 | |
| 2018-03-30 | -$16.80M 10-Q · filed 2019-05-07 | |
| 2017-12-29 | -$14.40M 10-Q · filed 2019-11-05 | -$12.90M 10-K · filed 2018-02-27 |
| 2017-09-29 | -$13.10M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | -$8.00M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | -$9.90M 10-Q · filed 2018-05-08 | |
| 2016-12-30 | -$72.50M 10-K · filed 2019-02-26 | |
| 2016-09-30 | -$85.60M 10-K · filed 2018-02-27 | |
| 2016-06-24 | -$65.70M 10-Q · filed 2017-08-08 | |
| 2016-03-25 | -$65.10M 10-Q · filed 2017-05-08 | |
| 2015-12-25 | -$65.30M 10-Q · filed 2017-11-07 | |
| 2015-09-25 | $900.00K 10-K · filed 2018-02-27 | |
| 2015-06-26 | $17.70M 10-Q · filed 2016-08-02 | |
| 2015-03-27 | $7.90M 10-Q · filed 2016-05-03 | |
| 2014-12-26 | $44.40M 10-Q · filed 2016-02-02 | |
| 2014-09-26 | $65.70M 10-K · filed 2016-11-29 | |
| 2014-06-27 | $110.50M 10-Q · filed 2015-08-04 | |
| 2014-03-28 | $106.40M 10-Q · filed 2015-05-05 | |
| 2013-12-27 | $108.70M 10-Q · filed 2015-02-03 | |
| 2013-09-27 | $108.50M 10-K · filed 2016-11-29 | |
| 2013-06-28 | $59.80M 10-Q · filed 2013-08-12 | |
| 2012-09-28 | $84.90M 10-K · filed 2015-11-24 | |
| 2011-09-30 | $98.50M 8-K · filed 2015-04-03 | |
| 2010-09-24 | $86.60M 10-K · filed 2013-12-13 |